Research for Patient Benefit Programme- South West Competition 51 Stage 1 Competition 50 Stage 2 Minutes

Minutes for the Research for Patient Benefit (RfPB) programme South West Regional Advisory Committee meeting to discuss Stage 2 applications to Competition 50 and Stage 1 applications to Competition 51.

Date and Location

Friday 29 September 2023 at Delta Hotels, Bristol.

In attendance

Committee members

Professor Robert Hinchliffe
Dr Rebecca Abbott
Dr Sarah Bailey
Professor Edward Carlton
Mr Simon Chilcott
Dr Ashwin Dhanda
Dr Rachel Johnson
Professor Antonieta Medina-Lara
Dr Siobhan O’Dwyer
Mrs Carol-Anne Partridge
Professor Shelley Potter
Dr Jenny Scott
Mrs Hilary Shergold
Professor Sarah Voss
Professor Tom Wainwright

Secretariat

Mr Simon Goodwin (NIHRCC)
Dr Kasia Kuleszewicz (NIHRCC)
Mr Ethan Coyle (NIHRCC)
Ms Daniela Stremtan (NIHRCC)

Competition 50 Stage 2 applications considered

NIHR206198: Preventing kidney injury using carbon dioxide as contrast medium in patients with Peripheral Arterial Disease (PAD) and Chronic Kidney Disease (CKD) having arterial intervention: the KID trial.
Conflicts: Professor Robert Hinchliffe

Final outcome: Conditional support

NIHR206215: Development and formative evaluation of an online resource for patients and professionals based on a qualitative investigation of the experience of living with Mast Cell Activation Syndrome (MCAS)
Conflicts: None

Final outcome: Reject

NIHR206192: ‘Love my Lungs’: Feasibility study to test delivery and preliminary evaluation of a smokefree home intervention for families of babies admitted to neonatal intensive care
Conflicts: None

Final outcome: Reject

NIHR206227: Using surface neuromuscular electrical stimulation for lower limb weakness early afterstroke: A randomised controlled feasibility study
Conflicts: Professor Thomas Wainwright

Final outcome: Conditional support

NIHR206784: OPTimising IMmunosuppression for older Adult kidney transpLant recipients (the OPTIMAL Trial): a feasibility study
Conflicts: Professor Robert Hinchliffe and Dr Rachel Johnson

Final outcome: Conditional support

Competition 51 Stage 1 applications considered

NIHR206603: Rare AutoImmune SElf-management programme development (RAISE)
Conflicts: Professor Robert Hinchliffe, Dr Elsa Marques, Professor Sarah Voss, Dr Rachel Johnson and Dr Jenny Scott

Outcome: Invite to Stage 2

NIHR206583: Improving patient safety when introducing new surgical procedures: developing methods for surgeons to share learning to optimise patient outcomes and avoid harm
Conflicts: Professor Robert Hinchliffe, Dr Elsa Marques, Miss Shelley Potter, Professor Sarah Voss

Outcome: Invite to Stage 2

NIHR206735: Silver Triage – pre-hospital support for older people living with frailty
Conflicts: Professor Antonieta Medina-Lara

Outcome: Reject

NIHR206722: Understanding the lived experience and unmet needs of CHILdren and young people with Lichen sclerosus and their parents/carers (CHILL)
Conflicts: Professor Robert Hinchliffe, Professor Shelley Potter, Professor Edward Carlton and Dr Jenny Scott

Outcome: Invite to Stage 2

NIHR206607: Process evaluation of implementing the Baby Sleep Planner intervention into community care in England
Conflicts: Professor Robert Hinchliffe, Dr Elsa Marques, Professor Edward Carlton and Dr Julia Wade

Outcome: Reject

NIHR206593: Feasibility study for a randomised controlled trial of fish oils for improving cognition in women with menopause-related cognitive Impairment
Conflicts: Dr Rebecca Abbott, Dr Siobhan O'Dwyer, Dr Sarah Bailey and Professor Antonieta Medina-Lara

Outcome: Reject

NIHR206592: The Self-Harm Support for Parents Study: feasibility randomised controlled trial of a web-based intervention to support parents/carers of young people who self-harm
Conflicts: None

Outcome: Reject

NIHR206587: A Modernised Lifestyle Change Approach for People with Type 2 diabetes. A Development and Feasibility Study.
Conflicts: Dr Rebecca Abbott, Dr Siobhan O'Dwyer, Dr Sarah Bailey and Professor Antonieta Medina-Lara

Outcome: Reject

NIHR206663: Assessing patient benefit from prostate cancer screening using 15-year follow-up from the CAP (Cluster randomised trial of PSA testing for prostate cancer) randomised controlled trial to update cost-effectiveness modelling (CAPCE)
Conflicts: Professor Robert Hinchliffe, Professor Shelley Potter, Dr Rachel Johnson and Dr Sarah Bailey

Outcome: Reject

NIHR206582: Effective Communication Practices When Discussing Risk In Primary Care: A Qualitative Evidence Synthesis
Conflicts: Professor Sarah Voss

Outcome: Reject

NIHR206728: InfoRmation and AdvicE for AduLt PatIents with hEart ValvE Disease (The RELIEVED Study)
Conflicts: Dr Rachel Johnson

Outcome: Reject

Outcomes Table

The tables below display the mean scores for each application that was assessed in the regional assessment committee meeting. They exclude applications that were rejected during the scrutiny and triage processes. 

Stage 2

Stage 1